Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2016, Article ID 2634976, 7 pages
http://dx.doi.org/10.1155/2016/2634976
Research Article

Role of Histone Demethylases in Cardiomyocytes Induced to Hypertrophy

1Center of Biomedical Research Universidad de La Sabana (CIBUS), Chía, Colombia
2Fundación Cardioinfantil, Instituto de Cardiología, Bogotá, Colombia

Received 3 May 2016; Revised 17 August 2016; Accepted 22 August 2016

Academic Editor: Wen-Hwa Lee

Copyright © 2016 Wendy Rosales et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. N. Frey, H. A. Katus, E. N. Olson, and J. A. Hill, “Hypertrophy of the heart: a new therapeutic target?” Circulation, vol. 109, no. 13, pp. 1580–1589, 2004. View at Publisher · View at Google Scholar · View at Scopus
  2. W. L. Haskell, I.-M. Lee, R. R. Pate et al., “Physical activity and public health: updated recommendation for adults from the American College of Sports Medicine and the American Heart Association,” Circulation, vol. 116, no. 9, pp. 1081–1093, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. D. L. Mann and M. R. Bristow, “Mechanisms and models in heart failure: the biomechanical model and beyond,” Circulation, vol. 111, no. 21, pp. 2837–2849, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. T. Bupha-Intr, K. M. Haizlip, and P. M. L. Janssen, “Role of endothelin in the induction of cardiac hypertrophy in vitro,” PLoS ONE, vol. 7, no. 8, Article ID e43179, pp. 1–9, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. J. A. Hill and E. N. Olson, “Cardiac plasticity,” The New England Journal of Medicine, vol. 358, no. 13, pp. 1370–1380, 2008. View at Publisher · View at Google Scholar
  6. C. Abi Khalil, “The emerging role of epigenetics in cardiovascular disease,” Therapeutic Advances in Chronic Disease, vol. 5, no. 4, pp. 178–187, 2014. View at Publisher · View at Google Scholar
  7. S. R. Martinez, M. S. Gay, and L. Zhang, “Epigenetic mechanisms in heart development and disease,” Drug Discovery Today, vol. 20, no. 7, pp. 799–811, 2015. View at Publisher · View at Google Scholar · View at Scopus
  8. F. Lizcano and J. Garcia, “Epigenetic control and cancer: the potential of histone demethylases as therapeutic targets,” Pharmaceuticals, vol. 5, no. 9, pp. 963–990, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. R. Papait, C. Greco, P. Kunderfranco, M. V. G. Latronico, and G. Condorelli, “Epigenetics: a new mechanism of regulation of heart failure?” Basic Research in Cardiology, vol. 108, no. 4, article 361, pp. 1–8, 2013. View at Publisher · View at Google Scholar · View at Scopus
  10. K. Oyama, D. El-Nachef, Y. Zhang, P. Sdek, and W. R. MacLellan, “Epigenetic regulation of cardiac myocyte differentiation,” Frontiers in Genetics, vol. 5, article 375, 10 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. Q.-J. Zhang and Z.-P. Liu, “Histone methylations in heart development, congenital and adult heart diseases,” Epigenomics, vol. 7, no. 2, pp. 321–330, 2015. View at Publisher · View at Google Scholar · View at Scopus
  12. E. Willems and M. Mercola, “Jumonji and cardiac fate,” Circulation Research, vol. 113, no. 7, pp. 837–839, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. P. Mathiyalagan, S. T. Keating, X.-J. Du, and A. El-Osta, “Chromatin modifications remodel cardiac gene expression,” Cardiovascular Research, vol. 103, no. 1, pp. 7–16, 2014. View at Publisher · View at Google Scholar
  14. T. Angrisano, G. G. Schiattarella, S. Keller et al., “Epigenetic switch at Atp2a2 and Myh7 gene promoters in pressure overload-induced heart failure,” PLoS ONE, vol. 9, no. 9, Article ID e106024, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. Y. Tang, Z.-Y. Chen, Y.-Z. Hong et al., “Expression profiles of histone lysine demethylases during cardiomyocyte differentiation of mouse embryonic stem cells,” Acta Pharmacologica Sinica, vol. 35, no. 7, pp. 899–906, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. E. S. Pilka, T. James, and J. H. Lisztwan, “Structural definitions of Jumonji family demethylase selectivity,” Drug Discovery Today, vol. 20, no. 6, pp. 743–749, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. S. G. Gray, A. H. Iglesias, F. Lizcano et al., “Functional characterization of JMJD2A, a histone deacetylase- and retinoblastoma-binding protein,” The Journal of Biological Chemistry, vol. 280, no. 31, pp. 28507–28518, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. Huang, J. Fang, M. T. Bedford, Y. Zhang, and R.-M. Xu, “Recognition of histone H3 lysine-4 methylation by the double tudor domain of JMJD2A,” Science, vol. 312, no. 5774, pp. 748–751, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. R. J. Klose, K. Yamane, Y. Bae et al., “The transcriptional repressor JHDM3A demethylates trimethyl histone H3 lysine 9 and lysine 36,” Nature, vol. 442, pp. 312–316, 2006. View at Publisher · View at Google Scholar · View at Scopus
  20. Q.-J. Zhang, H.-Z. Chen, L. Wang, D.-P. Liu, J. A. Hill, and Z.-P. Liu, “The histone trimethyllysine demethylase JMJD2A promotes cardiac hypertrophy in response to hypertrophic stimuli in mice,” The Journal of Clinical Investigation, vol. 121, no. 6, pp. 2447–2456, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Lee, J. W. Lee, and S.-K. Lee, “UTX, a histone H3-lysine 27 demethylase, acts as a critical switch to activate the cardiac developmental program,” Developmental Cell, vol. 22, no. 1, pp. 25–37, 2012. View at Publisher · View at Google Scholar · View at Scopus
  22. K. Agger, P. A. C. Cloos, J. Christensen et al., “UTX and JMJD3 are histone H3K27 demethylases involved in HOX gene regulation and development,” Nature, vol. 449, no. 7163, pp. 731–734, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. Q. Hu, J. Chen, J. Zhang, C. Xu, S. Yang, and H. Jiang, “IOX1, a JMJD2A inhibitor, suppresses the proliferation and migration of vascular smooth muscle cells induced by angiotensin II by regulating the expression of cell cycle-related proteins,” International Journal of Molecular Medicine, vol. 37, no. 1, pp. 189–196, 2016. View at Publisher · View at Google Scholar · View at Scopus
  24. P. P. Das, Z. Shao, S. Beyaz et al., “Distinct and combinatorial functions of Jmjd2b/Kdm4b and Jmjd2c/Kdm4c in mouse embryonic stem cell identity,” Molecular Cell, vol. 53, no. 1, pp. 32–48, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. F. Lizcano, C. Romero, and D. Vargas, “Regulation of adipogenesis by nuclear receptor PPARγ is modulated by the histone demethylase JMJD2C,” Genetics and Molecular Biology, vol. 34, no. 1, pp. 19–24, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. G. G. Welstead, M. P. Creyghton, S. Bilodeau et al., “X-linked H3K27me3 demethylase Utx is required for embryonic development in a sex-specific manner,” Proceedings of the National Academy of Sciences of the United States of America, vol. 109, no. 32, pp. 13004–13009, 2012. View at Publisher · View at Google Scholar · View at Scopus
  27. X. Weng, L. Yu, P. Liang et al., “A crosstalk between chromatin remodeling and histone H3K4 methyltransferase complexes in endothelial cells regulates angiotensin II-induced cardiac hypertrophy,” Journal of Molecular and Cellular Cardiology, vol. 82, pp. 48–58, 2015. View at Publisher · View at Google Scholar · View at Scopus
  28. P. Chaturvedi and S. C. Tyagi, “Epigenetic mechanisms underlying cardiac degeneration and regeneration,” International Journal of Cardiology, vol. 173, no. 1, pp. 1–11, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. M. Hohl, M. Wagner, J.-C. Reil et al., “HDAC4 controls histone methylation in response to elevated cardiac load,” The Journal of Clinical Investigation, vol. 123, no. 3, pp. 1359–1370, 2013. View at Publisher · View at Google Scholar · View at Scopus